Announcements Trials
Browse Landscape

Phase

Phase 2 77Phase 1 66Phase 1/2 25Phase 3 10Phase EARLY_PHASE1 6Phase 4 5Phase 2/3 3Phase NA 2

Status

Completed 3Recruiting 2Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Tuberous Sclerosis 1Sturge-Weber Syndrome 1Cognitive Dysfunction 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 22Fluorouracil 21Radiotherapy 18Gemcitabine 17Docetaxel 16Oxaliplatin 15Paclitaxel 14Carboplatin 13Capecitabine 13Bevacizumab 13Leucovorin 11Cyclophosphamide 11Irinotecan 10Drug Therapy 10Cytarabine 9Saline Solution 7Magnetic Resonance Spectroscopy 7Letrozole 7Dexamethasone 7Rituximab 6Nivolumab 6Methotrexate 6Exercise 6Etoposide 6Electroporation 6Doxorubicin 6pembrolizumab 5Pemetrexed 5Metformin 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × Sirolimus × Clear all
NCT03826628 2023-09-08

Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex

Dermatology Specialties Limited Partnership

Phase 2/3 Completed
107 enrolled 24 charts

Tuberous Sclerosis

NCT03047980 2021-11-01

Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Phase 2/3 Completed
10 enrolled 11 charts

Sturge-Weber Syndrome, Cognitive Dysfunction

NCT00328770 2013-06-24

De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma

University of Alberta

Phase 2/3 Completed
70 enrolled 9 charts
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡